Related Experiment Video

Updated: Aug 20, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

[Peptic ulcer disease etiology, diagnosis and treatment]

Leokadia Bak-Romaniszyn1, Stanisław Wojtuń, Jerzy Gil

  • 1Klinika Pediatrii, Kardiologii Prewencyjnej i Immunologii Wieku Rozwojowego UM w Lodzi. kpgiczmp@mazurek.man.lodz.pl

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|December 18, 2004
PubMed

Insights

Peptic ulcer disease is primarily caused by increased acid, Helicobacter pylori, NSAIDs, and stress. Effective treatment focuses on H. pylori eradication using antibiotics and proton pump inhibitors for better outcomes.

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Pediatrics

Background:

  • Peptic ulcer disease (PUD) is a common gastrointestinal condition.
  • Key risk factors include elevated gastric acid, Helicobacter pylori (H. pylori) infection, NSAID use, and stress.
  • H. pylori is a significant factor influencing PUD diagnosis and management.

Purpose of the Study:

  • To outline the etiology, clinical features, diagnostic methods, and treatment strategies for peptic ulcer disease.
  • To emphasize the role of H. pylori in PUD and its impact on management.
  • To discuss current therapeutic approaches for PUD.

Main Methods:

  • Review of current literature on peptic ulcer disease.
  • Discussion of diagnostic procedures including gastroscopy and H. pylori testing.
  • Analysis of treatment protocols, focusing on H. pylori eradication and gastroprotection.

Main Results:

  • H. pylori infection is a primary cause of duodenal ulcers.
  • Gastroscopy and H. pylori tests are essential for accurate diagnosis.
  • Combination therapy with antibiotics and proton pump inhibitors is effective for H. pylori eradication and reducing recurrence.

Conclusions:

  • H. pylori eradication is the cornerstone of modern PUD treatment.
  • Combination therapy improves treatment outcomes and lowers ulcer recurrence rates.
  • Proton pump inhibitors and H2-inhibitors provide effective gastroprotection for non-H. pylori ulcers or long-term management.

More Related Videos

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia03:05

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia

Published on: February 16, 2024

Related Concept Videos

Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction01:25

Peptic Ulcer Disease I: Introduction

Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...